Iovance Biotherapeutics, Inc. (IOVA)
3.925
-0.08
(-1.88%)
USD |
NASDAQ |
Jun 09, 14:17
Iovance Biotherapeutics SG&A Expense (Quarterly) : 38.95M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Agenus, Inc. | 6.86M |
| Neurocrine Biosciences, Inc. | 318.50M |
| Amgen, Inc. | 1.602B |
| BioCryst Pharmaceuticals, Inc. | 94.55M |
| Imunon, Inc. | 1.969M |